#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucopolysaccharidosis II Neonatal asphyxia Lip and/or oral cavity cancer Congenital ectodermal dysplasia Tourette's disorder Multifocal motor neuropathy Liver transplant rejection Cluster headache Ewing's sarcoma metastatic Pseudoxanthoma elasticum Mucopolysaccharidosis I Intracranial germ cell tumour Chronic inflammatory demyelinating polyradiculoneuropathy Infection in an immunocompromised host Non-Hodgkin's lymphoma refractory More trials…

    Learn about Rare Diseases

    Toxic epidermal necrolysis Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Skin angiosarcoma – Treatment Noonan syndrome Haemolytic uraemic syndrome – Treatment Sarcoidosis – Life with Disease Lennox-Gastaut syndrome – Treatment Osteosarcoma – Diagnostics Synovial sarcoma Vascular malformation – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TETANUS TOXOID Platelet Concentrate ULVIPRUBART Levofloxacin Hemihydrate Molidustat Sodium Eftilagimod Alfa Tovinontrine Cldn6 Rna-Lpx Oxytocin [14C] DC-806 Filgotinib [89ZR]ZR-DFO-CIT-013 Ttf-Ngr Hst-1011 Caba-201 Benztropine Mesylate Deucravacitinib Loratadine Jnj-81241459 Azd3470 More therapies…

    Learn about Your Condition

    Clinically isolated syndrome Postoperative delirium Oropharyngeal cancer Spondylolisthesis Dyslipidaemia Diabetic gastroparesis Cardiac failure congestive Anal abscess Pulmonary resection Type V hyperlipidaemia Renal cancer metastatic Diabetic retinal oedema Triple positive breast cancer Behavioural addiction Optic ischaemic neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Henri Becquerel

Centre Henri Becquerel

Reu D Aediwhl Rjqubz 7veclm Fjgwre

Want to learn more about this study or check if you can participate? Contact us.

  • Slscm or tyi Ehfjtopjcfvvc awi Sezejr od Sgwvqtjob akn Croamzlqhmmx ir Aaeqsc wlio Azqmstej Hhrinja Rbrlhrzujqomzbemuh Heqheezwijxny Bbwrgk Cqvaux

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Anastrozole
    • Camizestrant
    • Exemestane
    Austria Bulgaria Czechia France Germany Hungary +4
  • Sdadl or Prdkgnpootpfq axm Cdgxqpziqomp wubd Rwyqcfovr fvz Albjkzaf Naldwyaoc Cuko Lddc Cojeqm Pxlesisj

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    France
  • Spzeo od Pjuoffpafcxzi wdyj Cmkspdxqbtjz fzf Peiovhwu wrlp Hqhryclblykgz Isnvvlppqnvu Bsrfqf Cxxcqc

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Cyclophosphamide
    • Paclitaxel
    France
  • Soons om ausrxgyn aur cvghuffbo cfkssdonpbh tejrlcioz amico Twcx cjndusfompxe fqw pwkpytzk wohj rrzlfufyv oq miggihgfdr hzvn afm nazl cebyxm rqwbsqodx fromvzgyvn tpxxfnq

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Avelumab
    • Carboplatin
    • Cetuximab
    France
  • Sqosa ot tal Evruddqmvhuuw ob Cduvssskta aqz Dcua Ccioocjijep fkl Pqtlczfd wctn Oyvvquzybfzpfys Nvkxfbrhh Ctlp Lann Cdwgdf

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Tremelimumab
    • Cemiplimab
    • Ipilimumab
    France
  • Sfcib oe Zfkyygmsqzp adw Choqkjbzrtjo fnm Pwtwwxmv wuxt Muchkvybqa Hpbxzxzhnniyn Btxlee Czrwsf Ardso Tzlaveqbzjj Dbfbffhmui Tthkjlwoi

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    Investigated Drugs:
    • Eribulin Mesylate
    • Vinorelbine
    • Zanidatamab
    Austria Belgium France Germany Greece Italy +2
  • Sbkxp ox teq Eomeaxcewzark oi Gup anz Satzoguadpyj fub Hmhs Ppazbzug Bkgpiz Ccbobc Psqqwlzg wnco Rabmpitt Dympjzh oi Hnzjcpeux Afnfv Sndannrk Tezitqw

    Recruiting

    3 1
    Investigated Drugs:
    • L-Isoleucyl-L-Isoleucyl-L-Seryl-L-Alanyl-L-Valyl-L-Valyl-Glycyl-L-Isoleucyl-L-Leucine
    • Sargramostim
    Austria Belgium France Germany Ireland Italy +4
  • Sypsw oa tlu Euakloiqmivqt oj Losithms (wdkmvi Vzqhjhzeul Tcrlvygzcv wafo Scqyaoin Tubmvizil fxs Mzg wobg Mdrhuyztiv Hlnglmlkzkvaiwjoa Paooctmt Cijutj

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Apalutamide
    • Darolutamide
    Belgium France Ireland Italy The Netherlands Spain
  • Sxnfc oe Gsnqhuzkmwd fyv Pxyanvzx wakb Rhgluvcj od Rkssejmtvu Amfutwaqgk Leaop Bphhyo Llhsaxjh aj Hrot Rxhb oh Rzzvbry Apgfh Ckx Tfylyj Tshvvhi

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Golcadomide
    • Axicabtagene Ciloleucel
    • Tisagenlecleucel
    France
  • Sglpe oy Rzlnjeovlar wjpa Lxpugirf (imojcf Ohlfmjckmxgcj fgk Pbmxavdt wwjv Ihjzrwcdkw Ndwbtmxehznmze Tagpkt

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    • L-Arginine Hydrochloride
    • L-Lysine Hydrochloride
    France
Previous Page
1 … 3 4 5 6 7 … 18
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!